ATTD 2026 highlights for parents of children with type 1 diabetes: what mattered most
ATTD 2026: What parents of children with type 1 diabetes need to know
If you are raising a child with type 1 diabetes, ATTD 2026 matters more than most conferences.
It is where the future shows up first.
Held in Barcelona, the Advanced Technologies & Treatments for Diabetes conference brings together global experts, researchers, and diabetes tech companies. What gets attention here often becomes what you see next at home.
This year, one message stood out:
Diabetes care is moving towards faster understanding, less effort, and fewer decisions....at the end of the day, that's what we as parents and carers, really want, isn't it?
What is ATTD and why should you care?
ATTD focuses on one thing. Making diabetes easier to manage.
That includes:
- Continuous glucose monitors (CGM)
- Insulin pumps and closed-loop systems
- Artificial intelligence in diabetes care
- Ketone monitoring and DKA prevention
- Real-life use of diabetes technology
For parents, this is important because it shapes:
- How often you need to check your phone
- How quickly you spot problems
- How much mental load you carry each day
This was why Paul @ Lewcose was there, checking to see what's next for parents and carers of T1....a little secret, it was amazing. SO much to look forward to in the next couple of years.
The biggest ATTD 2026 themes for type 1 diabetes
1. AI is starting to reduce thinking, not just give more data
For years, diabetes tech has given you numbers.
Now it is starting to give you answers.
At ATTD 2026, artificial intelligence was a major focus. The shift is clear:
- From data → to decisions
- From numbers → to meaning
For you as a parent, this matters.
You do not need more graphs.
You need to know:
- Is my child safe right now
- Are they heading low
- Are they drifting high
The best tools are now trying to show that faster. It's still not perfect, but there is sustained progress and that points to a better life for not only T1's themselves, but us parents too.
2. Closed-loop systems keep moving forward
Closed-loop systems were everywhere at ATTD.
These systems connect:
- CGM
- Insulin pump
- Algorithm
The goal is simple.
Reduce how much you need to intervene.
Key progress shown:
- Systems adjusting insulin every few minutes
- Work towards less manual carb counting
- Better overnight control
For parents, this is one of the biggest long-term wins.
Less manual work.
Less guesswork.
More stability.
3. CGM is no longer just about readings
CGM has changed how type 1 diabetes is managed.
But ATTD 2026 made something clear.
It is not about the number anymore.
It is about:
- Trends
- Direction
- Time in range
- What you do next
This is a key shift.
Because most stress does not come from numbers.
It comes from uncertainty...and the odd scare when the levels go too low!
4. Ketones and DKA are becoming a bigger focus
This was one of the most important takeaways.
Ketones got serious attention thsi year at ATTD.
Why?
Because:
- DKA can develop quickly
- Glucose alone does not tell the full story
- Many people still do not check ketones consistently
New research and discussion focused on:
- Earlier detection
- Continuous ketone monitoring
- Better awareness
For parents, this is critical.
You are not just watching glucose. You are managing risk.
5. Screening and earlier detection are growing
ATTD also focused on something earlier in the journey.
Screening.
There is a push to:
- Identify type 1 diabetes earlier
- Reduce DKA at diagnosis
- Give families more time to prepare
This shows where the field is heading.
From reacting late, to acting earlier.
6. Real life is finally part of the conversation
One of the strongest signals from ATTD 2026:
It is not just about clinical results anymore. It is about real life.
Some of the sessions that Lewcose attended focused on:
- Sleep
- Exercise
- School
- Daily routines
- Mental load
Because this is what actually matters to you.
What products and technology stood out?
Several companies shared updates that point to where things are going.
Dexcom
- Continued development of CGM systems
- Focus on usability and education
- Improvements in data interpretation
Medtronic (MiniMed)
- Expanded sensor options
- Integration with closed-loop systems
- Longer wear sensors
CamDiab
- Movement towards fully closed-loop features
- Reduced need for manual input
Senseonics
- Long-term CGM solutions
- Focus on consistency and adherence
Abbott
- Strong focus on ketones and DKA
- Highlighting gaps in real-world monitoring
The real takeaways for parents
If you strip everything back, this is what matters most.
- Technology is trying to reduce your workload
- Faster understanding is more important than more data
- Risk detection is improving, especially for ketones
- Automation is increasing
- Real-life use is finally being taken seriously
What this means for your day to day life
You are not looking for more features.
You are looking for:
- Fewer checks
- Faster clarity
- Less stress
- Better sleep
That is exactly where the industry is heading and that's exactly what we need. Companies striving to create technology that helps, not hinders diabetes management. We just need to keep reminding them that we're humans with a finite bankroll for treating type 1. Industry needs to be told to keep it affordable, this is happening with various organisations that I had the pleasure of meeting. DeDoc and the local equivalents like NIDoc.
Where Lewcose fits into this shift
There is one gap that still exists today.
You often have the data. But you still need to check your phone to see it. That is where Lewcose sits.
It takes CGM data and turns it into:
- Instant colour signals
- At-a-glance awareness
- Shared visibility in your home
So instead of checking constantly, you can see what matters straight away. Your CGM tells you the data, Glocose light SHOWS you. Big difference!
Explore how Glowcose works here:
https://www.lewcose.com/products/glowcose-light
Final thought
ATTD 2026 showed clear progress.
Better systems.
Smarter tools.
More focus on real life.
But the goal is still the same. Make type 1 diabetes easier to live with. Not just more advanced.
Here are some more images of my time there. I took many photos, here's a few that stand out. Looking forward to Paris in 2027!
Paul @ Lewcose
1 comment
l2zzz2